So fun joining @BIOS Community, thanks for hosting! Please tune in :)
Podcast🎙️: Future of ADCs
Dive into oncology with @DavidEpsteinRX in our BIOS podcast! We discuss David's career and leadership at Novartis, @SeagenGlobal acquisition by Pfizer, breakthrough ADC therapy, and more!
Shoutout: @FlagshipPioneer
Listen Now:
buff.ly/49cPr4n
Thank you for making this study possible $SGN @SeagenGlobal
Enfortumab vedotin & Pembrolizumab improving PFS & OS by 55% & 53% respectively compared to platinum based chemo in 1st line UC (+avelumab in 30%). Chemo has not been beaten before (despite multiple efforts). RR and CR of 68% & 29% is hard to beat. DOR not reached (1/3)#ESMO2023
3
907
A big congratulations to Pelican Harbor Seabird Station. Conserving #wildlife for future generations. Construction starts in the fall for new state of the art wildlife campus. News Release: PHSS Secures $4.4 Million Construction Loan for New Facility: conta.cc/3L0YwTC
2
507
David Epstein retweeted
“Living at the intersection of science and commercialization, for me, is among the most fun thing you can do...”
Derived from our podcast w/ @DavidEpsteinRX - CEO @SeagenGlobal on his career north star💫
For the full episode, tune in here: ow.ly/LuJJ50P01Uq
David Epstein retweeted
Kicking off #ASCO23 Sunday with Seagen’s David Epstein talking about moving ADCs into broader indications. And, yes, asked him about the FTC review. biotechtv.com/post/david-eps…
Pelican Harbor Seabird Station is excited to announce the arrival of our 2022 #AnnualReport. We are so proud of all that we accomplished together last year and happy to share these achievements with YOU, our incredible supporters, donors, and friends.
static1.squarespace.com/stat…
1
290
David Epstein retweeted
The 300 current drug shortages, primarily affecting old, generic injectable drugs, result from structural woes in how these drugs are reimbursed by federal programs like Medicare that prevent generic makers from earning sufficient return to reinvest in modern secure manufacturing
The federal government capping the cost of certain drugs will "exacerbate" current drug shortages, former FDA Commissioner @ScottGottliebMD tells @margbrennan.
"It will prevent these generic manufacturers from being able to take price increases."
I had the opportunity to speak with @PSBJ to discuss the future of Seagen and impact of our proposed combination with @Pfizer. From a larger global reach to more resources to research, develop and deliver medicines to patients, I look forward to all that’s ahead for @SeagenGlobal
This Post is from an account that no longer exists. Learn more
1
5
494
Seagen - Pfizer Invests $43 Billion to Battle Cancer
Very proud to share that Seagen has entered into a definitive agreement to be acquired by Pfizer. A deal which will bring our innovative cancer medicines more quickly to patients all around the world investor.seagen.com/press-re…
4
4
546
This Burrowing Owl, a 2017 listed Threatened species, was admitted last week after being found stuck in a hurricane shutter. These birds previously inhabited the grasslands of central Florida that have now been lost to development and farmland. WWW.PelicanHarbor.org
3
306
I’m proud of the Seagen team’s strong performance in 2022, and I look forward to data and regulatory catalysts in 2023 that will help us build a more global oncology leader to address the needs of people living with cancer. $SGEN
This Post is from an account that no longer exists. Learn more
David Epstein retweeted
The question of whether employees feel a sense of belonging is a serious concern. wired.trib.al/6x6MWdl
David Epstein retweeted
I know there are interesting new work models out there and perhaps some who will pull it off, but I’m pretty sure you can’t build future @alnylam @regeneron @genentech virtually!
Biotech needs to get back to work in person, now! With our mission of bringing breakthru Rx to patients, in-person work fosters culture, engagement, creativity, and prof development. My $0.02. timmermanreport.com/2023/01/…
I agree. High performing teams that want to be both creative and productive need to spend time with each other. In addition it is very difficult to coach and develop future company leaders without seeing them in action. We owe it to our patients and employees. @SeagenGlobal
Biotech needs to get back to work in person, now! With our mission of bringing breakthru Rx to patients, in-person work fosters culture, engagement, creativity, and prof development. My $0.02. timmermanreport.com/2023/01/…
David Epstein retweeted
Biotech needs to get back to work in person, now! With our mission of bringing breakthru Rx to patients, in-person work fosters culture, engagement, creativity, and prof development. My $0.02. timmermanreport.com/2023/01/…
Axcella Announces Positive Interim Data from Phase 2b EMMPACT Study of AXA1125 in Nonalcoholic Steatohepatitis (NASH) | Business Wire businesswire.com/news/home/2…
Axcella shows highly statistically improvement in physical&mental fatique in severe long covid fatique patients. We will engage regulators on a potential pivotal trial. The need is great and AXA1125 is the first to show patient reported outcomes. #longcovid #fatigue @Ax_Health
Looking forward to clinical data on AXA1125 for Long Covid Fatigue fiercebiotech.com/biotech/ax…
David Epstein retweeted
We are thrilled to announce the launch of Logica, a customized turnkey drug discovery solution from target to preclinical development. @ValoHealth and @CRiverLabs are transforming #drugdiscovery with Logica, learn more here: tinyurl.com/3dfu87zj





















